Tsuruha Holdings Inc. (TYO:3391)
Japan
· Delayed Price · Currency is JPY 2,813.50
+14.00 (0.50%)
At close: Dec 5, 2025
Tsuruha Holdings Revenue
In the fiscal year ending February 28, 2025, Tsuruha Holdings had annual revenue of 1.01T JPY, down -1.24%. Tsuruha Holdings had revenue of 285.30B in the quarter ending August 31, 2025, with 4.42% growth.
Revenue
1,014.72B
Revenue Growth
+0.19%
P/S Ratio
0.68
Revenue / Employee
89.81M
Employees
11,298
Market Cap
685.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1,014.72B | -12.74B | -1.24% |
| May 15, 2024 | 1,027.46B | 57.38B | 5.92% |
| May 15, 2023 | 970.08B | 54.38B | 5.94% |
| May 15, 2022 | 915.70B | -3.60B | -0.39% |
| May 15, 2021 | 919.30B | 78.27B | 9.31% |
| May 15, 2020 | Pro | Pro | Pro |
| May 15, 2019 | Pro | Pro | Pro |
| May 15, 2018 | Pro | Pro | Pro |
| May 15, 2017 | Pro | Pro | Pro |
| May 15, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |